Fig. 3
From: Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China
![Fig. 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-4303-z/MediaObjects/12885_2018_4303_Fig3_HTML.gif)
Waterfall plot of best change from baseline for 21 soft tissue sarcoma patients
From: Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China
Waterfall plot of best change from baseline for 21 soft tissue sarcoma patients